Prospectus

Avalo Therapeutics, Inc. Filed 2017-08-14 Acc 0001628280-17-008666

Documents 1

2017-08-25 424B3 Prospectus
2017-08-21 4 Changes in Ownership
2017-08-16 4 Changes in Ownership
2017-08-14 424B3 Prospectus
2017-08-14 10-Q Quarterly Report
2017-08-14 424B3 Prospectus
2017-08-14 8-K Material agreement · Acquisition or sale completed · Results of operations · Executive or director change · Regulation FD disclosure

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading cerc424b320170814.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…